Masanori Asakura Selected Research

Chronic Renal Insufficiency

1/2022	Aortic plaque burden predicts vascular events in patients with cardiovascular disease: The EAST-NOGA study.
1/2018	An Exploratory Study of Dapagliflozin for the Attenuation of Albuminuria in Patients with Heart Failure and Type 2 Diabetes Mellitus (DAPPER).
11/2014	Pathophysiological impact of serum fibroblast growth factor 23 in patients with nonischemic cardiac disease and early chronic kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masanori Asakura Research Topics

Disease

58	Heart Failure 05/2024 - 10/2003
24	Myocardial Infarction 10/2022 - 01/2002
19	Infarction (Infarctions) 10/2018 - 01/2002
16	Reperfusion Injury 12/2017 - 01/2002
13	Cardiomegaly (Heart Hypertrophy) 11/2023 - 01/2002
11	Ischemia 01/2019 - 01/2002
8	Fibrosis (Cirrhosis) 11/2023 - 05/2013
8	Hypertrophy 01/2019 - 09/2002
8	Myocardial Ischemia (Ischemic Heart Diseases) 02/2016 - 07/2002
8	Body Weight (Weight, Body) 12/2012 - 09/2002
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2010
7	Diabetes Mellitus 01/2019 - 10/2006
6	Stroke (Strokes) 01/2022 - 01/2011
6	ST Elevation Myocardial Infarction 10/2017 - 01/2014
5	Anemia 11/2023 - 11/2017
5	Hypertension (High Blood Pressure) 11/2023 - 09/2011
5	Atrial Fibrillation 11/2022 - 04/2017
5	Neoplasms (Cancer) 09/2017 - 03/2002
4	Type 2 Diabetes Mellitus (MODY) 12/2023 - 05/2010
4	Hypoxia (Hypoxemia) 11/2023 - 01/2014
4	Left Ventricular Dysfunction 01/2023 - 01/2014
4	Cardiomyopathies (Cardiomyopathy) 07/2021 - 10/2007
4	Glucose Intolerance 08/2017 - 10/2006
4	Coronary Occlusion 09/2016 - 01/2002
3	Albuminuria 05/2024 - 01/2018
3	Ventricular Remodeling 12/2023 - 08/2006
3	Peripheral Arterial Disease 02/2023 - 05/2021
3	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 10/2018
3	Muscular Dystrophies (Muscular Dystrophy) 01/2022 - 02/2018
3	Chronic Renal Insufficiency 01/2022 - 11/2014
3	Unstable Angina 01/2021 - 08/2017
3	Bradycardia 01/2019 - 02/2009
3	Hypotension (Low Blood Pressure) 12/2017 - 10/2007
3	Heart Diseases (Heart Disease) 04/2015 - 01/2011
2	Iron Deficiencies 11/2023 - 01/2022
2	Death (Near-Death Experience) 01/2022 - 04/2015
2	Hypersensitivity (Allergy) 07/2021 - 10/2018
2	Ureteral Obstruction 01/2020 - 07/2018

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 03/2016 - 09/2002
10	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 08/2006
8	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2017 - 01/2002
8	Adenosine (Adenocard)FDA LinkGeneric 05/2015 - 01/2002
6	Adenosine Triphosphate (ATP)IBA 02/2015 - 09/2002
5	IronIBA 11/2023 - 11/2017
5	Hemoglobins (Hemoglobin)IBA 11/2023 - 07/2019
5	Glucose (Dextrose)FDA LinkGeneric 09/2020 - 10/2006
5	AdiponectinIBA 10/2018 - 06/2009
4	Biomarkers (Surrogate Marker)IBA 05/2024 - 08/2014
4	DiureticsIBA 01/2023 - 08/2014
4	tranilastIBA 01/2022 - 01/2018
4	Atrial Natriuretic Factor (ANF)IBA 01/2022 - 02/2004
4	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2019 - 05/2013
4	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 11/2018 - 01/2002
4	Nicorandil (SG 75)IBA 10/2017 - 02/2004
4	CytokinesIBA 09/2017 - 06/2009
4	Purinergic P1 Receptors (Adenosine Receptor)IBA 05/2015 - 01/2002
4	5'-Nucleotidase (5' Nucleotidase)IBA 06/2008 - 09/2003
4	Phosphotransferases (Kinase)IBA 02/2004 - 09/2002
4	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2003 - 01/2002
3	SaltsIBA 11/2023 - 01/2019
3	Eplerenone (Inspra)FDA LinkGeneric 01/2023 - 04/2015
3	Troponin T (Troponin T1)IBA 10/2022 - 02/2004
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2019 - 09/2002
3	Hormones (Hormone)IBA 02/2017 - 05/2013
3	Sodium-Hydrogen ExchangersIBA 04/2016 - 01/2014
3	3- guanidinocarbonyl- 2- methyl- 6,7,8,9- tetrahydro- 5H- cyclohepta(b)pyridine- 9- ylmethyl sulfuric acidIBA 04/2016 - 01/2014
3	Messenger RNA (mRNA)IBA 01/2016 - 03/2010
3	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2015 - 05/2013
3	Histamine (Histamine Dihydrochloride)FDA Link 11/2010 - 05/2006
3	ErbB Receptors (EGF Receptor)IBA 03/2010 - 01/2002
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2010 - 01/2002
3	Angiotensin IIIBA 10/2006 - 10/2002
3	Nitric Oxide Synthase (NO Synthase)IBA 08/2004 - 01/2002
3	Endothelin-1 (Endothelin 1)IBA 10/2003 - 10/2002
3	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 04/2003 - 09/2002
2	AlbuminsIBA 12/2023 - 07/2022
2	CreatinineIBA 12/2023 - 07/2022
2	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2023 - 01/2018
2	dapagliflozinIBA 12/2023 - 01/2018
2	Lipoprotein(a)IBA 02/2023 - 05/2021
2	Natriuretic PeptidesIBA 01/2023 - 06/2009
2	Angiotensin Receptor AntagonistsIBA 01/2023 - 01/2018
2	candesartanIBA 01/2023 - 01/2018
2	azilsartanIBA 01/2023 - 01/2018
2	evolocumabIBA 10/2022 - 01/2022
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 06/2010
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022 - 10/2007
2	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2021
2	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 06/2010
2	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 02/2018
2	HDL CholesterolIBA 09/2020 - 08/2012
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2020 - 04/2009
2	beta Adrenergic ReceptorsIBA 01/2020 - 08/2004
2	Transferrin Receptors (Transferrin Receptor)IBA 01/2020 - 01/2019
2	SodiumIBA 01/2020 - 01/2018
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2019 - 05/2013
2	VildagliptinIBA 01/2019 - 05/2013

Therapy/Procedure

21	Therapeutics 05/2024 - 01/2002
11	Percutaneous Coronary Intervention 10/2022 - 02/2004
4	Patient Readmission 07/2022 - 10/2017